Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NADROPARIN vs NAFCILLIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NADROPARIN vs NAFCILLIN: Safety Overview

Metric NADROPARIN NAFCILLIN
Total FAERS Reports 676 215
Deaths Reported 57 18
Death Rate 8.4% 8.4%
Hospitalizations 355 98
Average Patient Age 56.3 yrs 50.7 yrs
% Female Patients 58.5% 50.5%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Eugia US LLC
Route N/A INTRAVENOUS
Marketing Status N/A Discontinued